Citation Impact
Citing Papers
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
2012
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
2018
Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD
2021
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat
2019
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
2016
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
2021 Standout
Schizophrenia risk from complex variation of complement component 4
2016 StandoutNature
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Preventive strategies for mental health
2018
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
2019
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
2020
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
2017
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
2018
The hidden therapist: evidence for a central role of music in psychedelic therapy
2018
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
2020
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
2017
Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases
2014
A composite immune signature parallels disease progression across T1D subjects
2019
Classic hallucinogens in the treatment of addictions
2015
Crisis Intervention Related to the Use of Psychoactive Substances in Recreational Settings - Evaluating the Kosmicare Project at Boom Festival
2015
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
2018
Potential Therapeutic Effects of Psilocybin
2017 Standout
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
2011
Psychiatry & the psychedelic drugs. Past, present & future
2017
Emotions and brain function are altered up to one month after a single high dose of psilocybin
2020
Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts
2020
Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
2021
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
2019 Standout
Psychedelics and Psychedelic-Assisted Psychotherapy
2020
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
2016
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Psychedelics
2016 Standout
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
2010
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
2014
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses
2020
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
2016
A comparison of random forest variable selection methods for classification prediction modeling
2019 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Altered network hub connectivity after acute LSD administration
2018
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Long-lasting subjective effects of LSD in normal subjects
2017
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
2018
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
2021
Neuroticism is associated with challenging experiences with psilocybin mushrooms
2017
The neural basis of psychedelic action
2022 Standout
Psychedelics and Mental Health: A Population Study
2013
Therapeutic Applications of Classic Hallucinogens
2016
A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment
2015
Spatiotemporal Brain Dynamics of Emotional Face Processing Modulations Induced by the Serotonin 1A/2A Receptor Agonist Psilocybin
2013
The claustrum’s proposed role in consciousness is supported by the effect and target localization of Salvia divinorum
2014
Tripping on nothing: placebo psychedelics and contextual factors
2020 Standout
Tolerance to LSD and DOB induced shaking behaviour: Differential adaptations of frontocortical 5-HT2A and glutamate receptor binding sites
2014
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
2012
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
2018
Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
2013
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
2015
Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
2017
Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk
2014
Psilocybin – Summary of knowledge and new perspectives
2013
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
2011
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
2014
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
2019
LSD enhances suggestibility in healthy volunteers
2014
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
2018
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations
2015
LSD enhances the emotional response to music
2015
The promises and perils of psychedelic pharmacology for psychiatry
2022
Psychedelics and Other Psychoplastogens for Treating Mental Illness
2021
Harm potential of magic mushroom use: A review
2011
Art Therapy for Psychosocial Problems in Children and Adolescents: A Systematic Narrative Review on Art Therapeutic Means and Forms of Expression, Therapist Behavior, and Supposed Mechanisms of Change
2020 Standout
Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity
2020
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
2014
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
2021
Taking Psychedelics Seriously
2018 Standout
Psychedelics and the essential importance of context
2018
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
2017 Standout
Animal Models of Serotonergic Psychedelics
2012
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
2014
Psychedelics, Personality and Political Perspectives
2017
Psychedelics not linked to mental health problems or suicidal behavior: A population study
2015
A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment
2013
Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas
2021
Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
2018
Metabolic Fate of Hallucinogenic NBOMes
2015
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
2015
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
2017
OpenML: An R package to connect to the machine learning platform OpenML
2017
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
2021
Pivotal mental states
2020
Effective connectivity changes in LSD-induced altered states of consciousness in humans
2019
Advanced Modelling of Soil Organic Carbon Content in Coal Mining Areas Using Integrated Spectral Analysis: A Dengcao Coal Mine Case Study
2024 Standout
Probability of Transition to Psychosis in Individuals at Clinical High Risk
2021
Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR
2020 StandoutNobel
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
2018
Serotonin and brain function: a tale of two receptors
2017
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
2019
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
2020
Gendered Manifestations of Depression and Help Seeking Among Men
2015
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
2020
LSD alters eyes‐closed functional connectivity within the early visual cortex in a retinotopic fashion
2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
2016
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
2020
Long-term follow-up of psilocybin-facilitated smoking cessation
2016 Standout
Comparison of topical silver nitrate and flunisolide treatment in patients with idiopathic non-allergic rhinitis.
1996
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
2011
American Trip
2020 Standout
Preventive psychiatry: a blueprint for improving the mental health of young people
2021
Models of psychedelic drug action: modulation of cortical-subcortical circuits
2021
Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations
2017
Preparing for the Bursting of the Psychedelic Hype Bubble
2022 Standout
Works of Erich Studerus being referenced
Prediction of Psilocybin Response in Healthy Volunteers
2012
Aberrant Current Source-Density and Lagged Phase Synchronization of Neural Oscillations as Markers for Emerging Psychosis
2014
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
2010
Predictors of study drop-out and service disengagement in patients at clinical high risk for psychosis
2019
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning – Results from the EU-GEI study
2019
Hippocampal volume in subjects at high risk of psychosis: A longitudinal MRI study
2012
Prediction of conversion to psychosis in individuals with an at-risk mental state
2017
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
2012
Help-seeking and pathways to care in the early stages of psychosis
2012
Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: A systematic review
2019
mlr: Machine Learning in R
2013
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
2010
Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice
2020
Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA
2008